IBDEI0FD ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7429,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,7430,0)
 ;;=V17.89^^55^580^18
 ;;^UTILITY(U,$J,358.3,7430,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7430,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,7430,1,5,0)
 ;;=5^Family h/o Musculosk Disease
 ;;^UTILITY(U,$J,358.3,7430,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,7431,0)
 ;;=V12.54^^55^580^56
 ;;^UTILITY(U,$J,358.3,7431,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7431,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,7431,1,5,0)
 ;;=5^Hx of TIA
 ;;^UTILITY(U,$J,358.3,7431,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,7432,0)
 ;;=V12.54^^55^580^52
 ;;^UTILITY(U,$J,358.3,7432,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7432,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,7432,1,5,0)
 ;;=5^Hx of Stroke w/o Residual
 ;;^UTILITY(U,$J,358.3,7432,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,7433,0)
 ;;=V15.88^^55^580^33
 ;;^UTILITY(U,$J,358.3,7433,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7433,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,7433,1,5,0)
 ;;=5^Hx of Fall(s)
 ;;^UTILITY(U,$J,358.3,7433,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,7434,0)
 ;;=V13.59^^55^580^42
 ;;^UTILITY(U,$J,358.3,7434,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7434,1,4,0)
 ;;=4^V13.59
 ;;^UTILITY(U,$J,358.3,7434,1,5,0)
 ;;=5^Hx of Musculosk Disease
 ;;^UTILITY(U,$J,358.3,7434,2)
 ;;=^295268
 ;;^UTILITY(U,$J,358.3,7435,0)
 ;;=V15.52^^55^580^55
 ;;^UTILITY(U,$J,358.3,7435,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7435,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,7435,1,5,0)
 ;;=5^Hx of TBI
 ;;^UTILITY(U,$J,358.3,7435,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,7436,0)
 ;;=V12.04^^55^580^38
 ;;^UTILITY(U,$J,358.3,7436,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7436,1,4,0)
 ;;=4^V12.04
 ;;^UTILITY(U,$J,358.3,7436,1,5,0)
 ;;=5^Hx of MRSA Infection
 ;;^UTILITY(U,$J,358.3,7436,2)
 ;;=^336780
 ;;^UTILITY(U,$J,358.3,7437,0)
 ;;=V13.51^^55^580^23
 ;;^UTILITY(U,$J,358.3,7437,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7437,1,4,0)
 ;;=4^V13.51
 ;;^UTILITY(U,$J,358.3,7437,1,5,0)
 ;;=5^Hs of Pathological Fx
 ;;^UTILITY(U,$J,358.3,7437,2)
 ;;=^336781
 ;;^UTILITY(U,$J,358.3,7438,0)
 ;;=V15.51^^55^580^58
 ;;^UTILITY(U,$J,358.3,7438,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7438,1,4,0)
 ;;=4^V15.51
 ;;^UTILITY(U,$J,358.3,7438,1,5,0)
 ;;=5^Hx of Traumatic Fx
 ;;^UTILITY(U,$J,358.3,7438,2)
 ;;=^336786
 ;;^UTILITY(U,$J,358.3,7439,0)
 ;;=V62.22^^55^580^49
 ;;^UTILITY(U,$J,358.3,7439,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7439,1,4,0)
 ;;=4^V62.22
 ;;^UTILITY(U,$J,358.3,7439,1,5,0)
 ;;=5^Hx of Return from Military Deployment
 ;;^UTILITY(U,$J,358.3,7439,2)
 ;;=^336807
 ;;^UTILITY(U,$J,358.3,7440,0)
 ;;=V70.0^^55^581^1
 ;;^UTILITY(U,$J,358.3,7440,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7440,1,4,0)
 ;;=4^V70.0
 ;;^UTILITY(U,$J,358.3,7440,1,5,0)
 ;;=5^Routine Med Exam
 ;;^UTILITY(U,$J,358.3,7440,2)
 ;;=^295590
 ;;^UTILITY(U,$J,358.3,7441,0)
 ;;=V77.91^^55^581^2
 ;;^UTILITY(U,$J,358.3,7441,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7441,1,4,0)
 ;;=4^V77.91
 ;;^UTILITY(U,$J,358.3,7441,1,5,0)
 ;;=5^Screen for High Cholesterol
 ;;^UTILITY(U,$J,358.3,7441,2)
 ;;=Screen for High Cholesterol^322093
 ;;^UTILITY(U,$J,358.3,7442,0)
 ;;=V76.44^^55^581^3
 ;;^UTILITY(U,$J,358.3,7442,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7442,1,4,0)
 ;;=4^V76.44
 ;;^UTILITY(U,$J,358.3,7442,1,5,0)
 ;;=5^Screen for Prostate CA
 ;;^UTILITY(U,$J,358.3,7442,2)
 ;;=Screen for Prostate CA^321548
 ;;^UTILITY(U,$J,358.3,7443,0)
 ;;=V74.5^^55^581^5
 ;;^UTILITY(U,$J,358.3,7443,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7443,1,4,0)
 ;;=4^V74.5
